Synthesis and Biodistribution of 11C-GW7845, a Positron-Emitting Agonist for Peroxisome ProliferatorActivated Receptor-
William B. Mathews, PhD1,
Catherine A. Foss, PhD1,
Doris Stoermer, PhD2,
Hayden T. Ravert, PhD1,
Robert F. Dannals, PhD1,
Brad R. Henke, PhD3 and
Martin G. Pomper, MD, PhD1
1 Department of Radiology, Johns Hopkins University, Baltimore, Maryland
2 Guilford Pharmaceuticals, Baltimore, Maryland
3 Research and Development, GlaxoSmithKline, Research Triangle Park, North Carolina

View larger version (19K):
[in a new window]
|
FIGURE 1. Synthesis of 11C-compound 1. OMe = methoxy (OCH3); Ki = inhibitor constant.
|
|

View larger version (12K):
[in a new window]
|
FIGURE 2. Binding selectivity of 11C-compound 1 at 60 min after injection (n = 3) in female SCID mice bearing MCF-7 tumors. Tissue distribution of 11C-compound 1 upon coinjection with unlabeled compound 1 at 2 mg/kg showed either equal or increased tracer uptake. Error bars indicate SDs.
|
|

View larger version (34K):
[in a new window]
|
FIGURE 3. (A) PET image showing in vivo distribution of 11C-compound 1 at 60 min after injection in SCID mice bearing MDA-MB-231 tumors. Tissue distribution of 11C-compound 1 after intraperitoneal administration of unlabeled compound 1 at 2 mg/kg showed either equal or increased tracer uptake. (B) CT image of same mice.
|
|
Copyright © 2005 by the Society of Nuclear Medicine.